Rankings
▼
Calendar
AMRN FY 2024 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$229M
-25.5% YoY
Gross Profit
$81M
35.6% margin
Operating Income
-$92M
-40.2% margin
Net Income
-$82M
-35.9% margin
EPS (Diluted)
$-4.00
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$31M
Stock-Based Comp.
$18M
Balance Sheet
Total Assets
$685M
Total Liabilities
$199M
Stockholders' Equity
$486M
Cash & Equivalents
$121M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$229M
$307M
-25.5%
Gross Profit
$81M
$166M
-50.8%
Operating Income
-$92M
-$68M
-35.8%
Net Income
-$82M
-$59M
-39.0%
← Q4 2023
All Quarters
Q1 2024 →